Jim Simons Purple Biotech Ltd. Transaction History

Renaissance Technologies LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$2.39 - $4.15 $120,169 - $208,662	-50,280 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$2.45 - $4.3 $123,186 - $216,204	50,280 New	50,280 $198,000
Q2 2021 Aug 13, 2021	SELL	$3.75 - $6.72 $821,381 - $1.47 Million	-219,035 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$3.93 - $6.99 $354,230 - $630,043	90,135 Added 69.93%	219,035 $905,000
Q4 2020 Feb 10, 2021	BUY	$3.81 - $4.73 $491,109 - $609,697	128,900 New	128,900 $491,000

2.64M

6.6K

Ticker PPBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 18,303,300
Market Cap $7.5M
Description
Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug for cancer patients in the United States. Its oncology pipeline includes CM24, a monoclonal antibody that blocks carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhi...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.